Methods and devices for intradermal injection

• US 8,556,861 B2
• Filed: 04/23/2008
• Issued: 10/15/2013
• Est. Priority Date: 04/23/2007
• Status: Active Grant

• Current Assignee: Program For Appropriate Technology In Health, Sid Technologies LLC
• Original Assignee: Program For Appropriate Technology In Health, Sid Technologies LLC
• Inventors: Tsals, Izrail
• Primary Examiner(s): STIGELL, THEODORE J
• Application Number:
  US12/597,103
• Publication Number:
  US 20100137831A1
• Time in Patent Office: 2,001 Days
• Field of Search: 604/110, 604/115, 604136-137, 604/157, 604/187, 604/192, 604/198, 604/263, 604/500, 604/506
• US Class Current: 604/187
• CPC Class Codes: A61M 2005/3247 Means to impede repositioning of protection sleeve from needle covering to needle uncovering position
• CPC Class Codes: A61M 5/3243 being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel devices for protecting guide needles in combination with catheters A61M25/0612
• CPC Class Codes: A61M 5/3271 with guiding tracks for controlled sliding of needle protective sleeve from needle exposing to needle covering position
• CPC Class Codes: A61M 5/3287 Accessories for bringing the needle into the body; Automatic needle insertion A61M5/20, A61M5/31525 take precedence
• CPC Class Codes: A61M 5/425 Protruding skin to facilitate piercing, e.g. vacuum cylinders, vein immobilising means
• CPC Class Codes: A61M 5/46 having means for controlling depth of insertion

Abstract

Devices and methods for intradermal (ID) administration of diagnostic and therapeutic agents, vaccines and other compounds into the dermal layer of the skin are disclosed. The devices and the methods simplify the ID injection process and increase the consistency of the placement of the needle tip in the dermal space close to the skin surface allowing for a shallow cannula placement in the dermis. Furthermore, the devices and methods broaden the number of sites suitable for ID injection and make the ID injection possible with limited training.

Claims

1. An adapter (100, 200, 310, 410, 510) for use with a syringe (50, 80, 350) provided with a needle cannula (55, 85, 345, 431, 531) for intradermal injection of a medicament into the skin of a patient comprising:

a body sized to receive in sliding engagement the needle cannula for movement of the needle cannula relative to the body between a first position and a second position;

a first primary skin contacting surface (104, 204, 323) positioned at a distal end of the body and containing an opening sized to receive the needle cannula;

a second primary skin contacting surface (105, 205, 311) positioned at the distal end of the body and further positioned at an angle (123, 223, 324) to the first skin contacting surface between approximately 120 degrees and approximately 165 degrees, the second primary skin contacting surface being fixed with respect to the first primary skin contacting surface and the second primary skin contacting surface being positioned distally with respect to the first primary skin contacting surface; and

a proximal contact surface extending proximally from a proximal end of the first primary skin contacting surface,

wherein;

in the first position, the needle cannula is positioned relative to the body such that at least a tip of the needle cannula is retracted within the opening and a longitudinal axis of the needle cannula extends at an angle of greater than 0° and

less than 180°

with respect to a plane defined by the proximal contact surface;

in the second position, the tip of the needle cannula extends through the opening and the tip of the needle cannula extends outside of the body and exterior to the second skin contacting surface;

in the second position, the needle cannula extends axially in a direction substantially parallel to at least a portion of the second primary skin contacting surface.

2. The adapter of claim 1, further comprising a distal contact surface (116, 216) adjacent the second primary skin contacting surface.

3. The adapter of claim 1, wherein at least a portion of the second primary skin contacting surface is substantially transparent to allow observation of the skin during the injection.

4. The adapter of claim 1, wherein a portion of the second primary skin contacting surface is removed to form an opening through which the skin of the patient may be observed during the injection.

5. The adapter of claim 1, wherein at least one of the first and second primary skin contacting surfaces is grooved to assist in tensioning the skin as the adapter is placed into contact with the patient'"'"'s skin.

6. The adapter of claim 1, wherein at least one of the first and second primary skin contacting surfaces is formed from a rubbery material that assists in tensioning the patient'"'"'s skin during the injection.

7. The adapter of claim 1, wherein the first and second primary skin contacting surfaces are configured so that in the second position, the tip of the needle cannula extends into the skin of the patient to a depth measured perpendicularly to the patient'"'"'s skin surface of between 0.25 mm and 3.0 mm.

8. The adapter of claim 1, wherein a portion of the second primary skin contacting surface is curved.

9. The adapter of claim 1, wherein the body, including the first and second primary skin contacting surfaces, and needle cannula are configured such that in the second position, approximately 1.0 to 8.0 mm of the needle cannula extends into the skin of the patient.

10. The adapter of claim 1, wherein an undercut (94) formed in a hub (93) of the syringe is positioned to engage a first latch (213) of the adapter to hold the syringe in the first position.

11. The adapter of claim 10, wherein following the injection, the tip of the needle cannula is permanently shielded within the body and the syringe is locked in position relative to the adapter by engagement of the first latch (213) and a second latch (232) with the hub undercut.

12. The adapter of claim 1, wherein:

the needle cannula is provided as part of a needle cannula assembly (330, 430, 530) slidably connected to the adapter, and

the needle cannula assembly includes a hub (331, 436, 536) sized and shaped to mate with a fitting on the syringe.

13. The adapter of claim 12, wherein the hub includes a first radial protrusion (433) and the body has a matching axial opening (415) to control angular orientation of the hub relative to the adapter in movement from the first position to the second position.

14. The intradermal needle assembly of claim 13, further comprising a clip retainer that prevents accidental activation of the intradermal needle assembly during merger with a drug delivery device.

15. The intradermal needle assembly of claim 13, wherein the needle cannula assembly comprises two protrusions arranged to slide in openings of the adapter wherein one protrusion of the needle cannula assembly is flexibly attached to the needle cannula assembly body and one protrusion is rigidly fixed to the needle cannula assembly body.

16. The intradermal needle assembly of claim 15, wherein engagement of the rigidly fixed protrusion in the adapter opening prevents distal motion of the needle hub during merger with a drug delivery device and guides the cannula assembly distally for the cannula insertion when the needle cannula assembly is rotated in respect to the adapter.

17. The intradermal needle assembly of claim 13, additionally comprising an integral dermis sensor that prevents relative component displacement during merger with a drug delivery device and prior to needle cannula application to the dermis.

18. The intradermal needle assembly of claim 17, wherein the integral dermis sensor is activated while the adapter is applied to the injection site enabling the cannula insertion.

19. The intradermal adapter of claim 17, wherein the integral dermis sensor is captured by a protrusion of the intradermal cannula assembly upon cannula withdrawal with the cannula permanently shielded.

20. The adapter of claim 12, wherein the hub includes a second radial protrusion (432) and the body has a matching axial opening (411) which prevents distal motion of the syringe during assembly of the needle cannula assembly and the syringe.

21. The adapter of claim 12, further comprising a rotatable dermis sensor element (551) and a latching element (511) in cooperative engagement with the needle cannula assembly, wherein:

the dermis sensor and latching element are biased into a first configuration blocking distal movement of the needle cannula assembly;

upon contact of the dermis sensor with the patient'"'"'s skin, the dermis sensor and latching element are moved into a second configuration allowing distal movement of the needle cannula assembly.

22. The adapter of claim 21, wherein following the injection and upon movement of the needle cannula assembly in a proximal direction, the dermis sensor is further rotated into a position such that the latching element is moved to a position blocking distal movement of the needle cannula.

23. The intradermal needle assembly of claim 22, wherein the needle cannula is permanently shielded by the needle cannula assembly being moved into a discard position of the adapter wherein the protrusion proximal slope elevates the latch to move the protrusion into the second latch opening.

24. A method of making an intradermal injection into the skin comprising the steps of:

providing an intradermal needle assembly comprising a needle cannula with a forward needle tip and an integral adapter surrounding the needle cannula, the adapter having a first skin contacting surface, a second skin contacting surface, and a proximal contact surface extending proximally from a proximal end of the first skin contacting surface, the needle cannula being in fluid communication with a drug delivery device, a longitudinal axis of the needle cannula extending at an angle of greater than 0° and

less than 180°

with respect to a plane defined by the proximal contact surface, the first and second skin contacting surfaces being positioned at a distal end of the assembly, the second skin contacting surface being positioned distally with respect to the first skin contacting surface;

engaging the first and second skin contacting surfaces and the proximal contact surface with the skin;

inserting the needle cannula into the dermis layer of the skin through an opening in the first skin contacting surface, wherein the needle cannula is further inserted in the dermis generally parallel to the second skin contacting surface;

expelling a fluid from the drug delivery device into the dermis; and

removing the intradermal needle assembly from the skin.

25. The method of claim 24 wherein pressure on the skin is minimized while the fluid is expelled from the drug delivery device.

26. The method of claim 24 wherein the needle is shielded after removal of the intradermal needle assembly from the skin.

27. The method of claim 24 wherein the intradermal needle assembly is withdrawn from the skin prior to the removal of the needle adapter from the tissue.

28. The method of claim 24 wherein a safety clip maintains the needle assembly in position relative to the adapter during the merger of the intradermal needle assembly with the drug delivery device.

29. A method of making an intradermal injection into the skin comprising the steps of:

providing an intradermal needle assembly having a forward needle tip and an integral adapter surrounding the needle cannula, the adapter having two surfaces for contacting the skin and the needle cannula being in fluid communication with a drug delivery device;

engaging the contact surfaces of the adapter with the skin and maintaining contact of the skin with both adapter contact surfaces;

slightly turning a needle hub counterclockwise as defined by a hub pin position to enable distal travel of the hub;

inserting the needle into the dermis layer of the skin through an opening in one of the contact surfaces, wherein the needle cannula enters the dermis through the first surface and is further inserted in general parallel to the skin surface;

expelling the compound from the drug delivery device into the dermis; and

removing, shielding, and discarding the needle assembly.

30. A method as set forth in claim 29 wherein a hub protrusion of the cannula assembly positioned in an adapter opening prevents distal movement of the cannula assembly during the merger of the intradermal needle assembly with the drug delivery device.

31. A method of making an intradermal injection into the skin comprising the steps of:

providing an intradermal needle assembly having a forward needle tip, an integral adapter surrounding the needle cannula and a dermis sensor, the adapter having two surfaces for contacting the skin and the needle cannula being in fluid communication with a drug delivery device;

engaging the contact surfaces of the adapter with the skin and maintaining contact of the skin with both adapter contact surfaces;

activating the dermis sensor while contacting the skin and maintaining the contact;

inserting the needle into the dermis layer of the skin through an opening in one of the contact surfaces, wherein the needle cannula enters the dermis through the first surface and is further inserted generally parallel to the skin surface;

expelling the compound from the drug delivery device into the dermis; and

removing and shielding the cannula whereby the assembly is permanently disabled for safe discard.

32. A method as set forth in claim 31 wherein the dermal sensor prevents distal movement of the cannula assembly during the merger of the intradermal needle assembly with the drug delivery device and permanently disables the assembly after use.

33. A method for providing an intradermal injection, comprising:

contacting a skin surface with first and second skin contacting surfaces and a proximal contact surface of an adapter device having a drug delivery device mounted in an internal cavity, the first and second skin contacting surfaces being arranged at an angle of less than 180°

relative to one another, the first and second skin contacting surfaces being positioned at a distal end of the assembly, the second skin contacting surface being positioned distally with respect to the first skin contacting surface, the proximal contact surface extending proximally from a proximal end of the first skin contacting surface;

inserting a needle cannula of the drug delivery device through an opening in the adapter device and into the skin, a longitudinal axis of the needle cannula extending at an angle of greater than 0° and

less than 180°

with respect to a plane defined by the proximal contact surface; and

extending the needle cannula into the dermal layer along a path generally parallel to and below the second skin contacting surface.